
    
      The main objective of this study is to evaluate the effect of reducing LDL-C levels after 12
      months of administration of Statin Monotherapy or Rosuzet Tab.(Rosuvastatin/Ezetimibe) in
      patients with dyslipidemia in Korea
    
  